Celsus, Inc. manufactures bulk heparins and develops other complex macromolecules belonging to the family of glycosaminoglycans (GAGs). The Company's tradename evokes the name of Aulus Cornelius Celsus, a first-century Roman medical encyclopedist. Celsus Laboratories, Inc., a wholly-owned subsidiary company, is a USDA-approved, FDA-audited drug establishment with the capacity to manufacture and test GAGs used in injectable drugs, blood collection, blood gas analysis, thromboresistant coatings for blood-interacting medical devices, and immobilized GAGs. Celtone, Inc., also a wholly-owned subsidiary, manufactures crude GAGs and protein hydrolysates by a patented process. IntimaX Corporation is an affiliate for the clinical development of the proprietary targeted anticoagulant and heparin cofactor II agonist, Intimatanâ¢
